论文部分内容阅读
目的分析胺碘酮治疗急性心肌梗死并心房颤动的临床效果。方法 82例急性心肌梗死并心房颤动患者,随机分为观察组与对照组,各41例。观察组患者接受胺碘酮治疗,对照组患者接受普罗帕酮治疗,对两组患者治疗效果、不良反应发生情况进行对比。结果观察组总有效率为90.24%,对照组总有效率为70.73%,比较差异有统计学意义(P<0.05);观察组不良反应发生率为7.32%,对照组不良反应发生率为24.39%,比较差异有统计学意义(P<0.05)。结论胺碘酮治疗急性心肌梗死并心房颤动的临床效果显著,且药物安全性高,可在临床上进行推广。
Objective To analyze the clinical effect of amiodarone in the treatment of acute myocardial infarction with atrial fibrillation. Methods 82 patients with acute myocardial infarction and atrial fibrillation were randomly divided into observation group and control group, 41 cases in each. Patients in the observation group were treated with amiodarone, and patients in the control group were treated with propafenone. The therapeutic effects and the adverse reactions of the two groups were compared. Results The total effective rate was 90.24% in the observation group and 70.73% in the control group, with significant difference (P <0.05). The incidence of adverse reactions in the observation group was 7.32% and the incidence of adverse reactions in the control group was 24.39% , The difference was statistically significant (P <0.05). Conclusion The clinical effect of amiodarone in treating acute myocardial infarction with atrial fibrillation is remarkable, and the drug is safe and can be popularized clinically.